ACTT is now part of the PPD Select Partnership Program.

Our long-standing collaboration with the PPD clinical research business of Thermo Fisher Scientific has now evolved into our inclusion in the PPD Select Partnership Program.

This milestone reflects a shared commitment to delivering high-quality, globally connected clinical research. By aligning more closely, we strengthen our ability to support complex Phase Ib–III trials, combining global expertise with local capability across our two sites in Aotearoa New Zealand.

Together, this partnership expands what we can deliver - enabling greater access to innovative studies, improving trial delivery at scale, and increasing opportunities for patients and communities to participate in cutting-edge research.

We look forward to continuing to work alongside the PPD clinical research team to bring more clinical trials to Aotearoa New Zealand, advancing research through collaboration and delivering better outcomes for the communities we serve.

#ClinicalResearch #ACTT #GlobalCollaboration